Alhambra Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-3,219
| Closed | -$833K | – | 162 |
|
|
2023
Q4 | $833K | Sell |
3,219
-724
| -18% | -$187K | 0.49% | 52 |
|
|
2023
Q3 | $1.01M | Sell |
3,943
-236
| -6% | -$60.7K | 0.67% | 43 |
|
|
2023
Q2 | $1.19M | Sell |
4,179
-21
| -0.5% | -$5.98K | 0.79% | 32 |
|
|
2023
Q1 | $1.17M | Buy |
4,200
+113
| +3% | +$31.4K | 0.8% | 31 |
|
|
2022
Q4 | $1.13M | Sell |
4,087
-848
| -17% | -$235K | 0.82% | 33 |
|
|
2022
Q3 | $1.32M | Buy |
4,935
+181
| +4% | +$48.3K | 1% | 28 |
|
|
2022
Q2 | $970K | Buy |
4,754
+155
| +3% | +$31.6K | 0.7% | 36 |
|
|
2022
Q1 | $969K | Buy |
4,599
+586
| +15% | +$123K | 0.64% | 40 |
|
|
2021
Q4 | $963K | Buy |
4,013
+882
| +28% | +$212K | 0.67% | 38 |
|
|
2021
Q3 | $886K | Buy |
3,131
+200
| +7% | +$56.6K | 0.68% | 41 |
|
|
2021
Q2 | $1.02M | Buy |
2,931
+42
| +1% | +$14.5K | 0.76% | 32 |
|
|
2021
Q1 | $808K | Buy |
2,889
+1,150
| +66% | +$322K | 0.65% | 38 |
|
|
2020
Q4 | $426K | Sell |
1,739
-19
| -1% | -$4.65K | 0.45% | 77 |
|
|
2020
Q3 | $499K | Buy |
+1,758
| New | +$499K | 0.6% | 52 |
|